Science Business News

Enable Injections, Inc., a company developing and manufacturing investigational wearable infusion devices for combination products, today announced it has entered into a development agreement with Genentech, a member of the Roche Group. The enFuse™, under development by Enable, will enable patient-administered subcutaneous delivery of high-volume therapeutics.

Now seven months along, the webinar series that Science and Fondation Ipsen launched in January 2019 -- to openly address topics many people believe scientists should be evaluating more critically -- is having the hoped-for impact.

Scientists from NUST MISIS together with colleagues from Lomonosov Moscow State University have developed a method for quick and effective analysis of the composition of water, which will help to solve the problem of industrial pollution. The methodology is based on the use of environmentally friendly nanoparticles with fluorescent properties. The method is also suitable for hard-to-reach or remote sources of water.

USC-led team adds RNA sequencing data to its massive Parkinson's database; collaboration with Michael J. Fox Foundation could help identify some of the earliest hallmarks of the disease.

Calibr, the drug development division of Scripps Research, announced today that the US Food and Drug Administration (FDA) has cleared its investigational new drug application (IND) for CCW702, a novel immunotherapeutic for the treatment of patients with metastatic castration-resistant prostate cancer. CCW702 has the potential to be effective in patients who have failed prior treatments and have exhausted their treatment options, as it works differently than traditional chemotherapeutics and androgen deprivation therapies.

Some contaminant yeasts make beer bottles and cans explode. VTT scientists developed a genetic test for brewers to detect the strains that cause these problems.